We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Complex Inheritance Pattern Linked to Gene Changes

By Biotechdaily staff writers
Posted on 24 May 2002
Three separate genetic regions, parts of chromosomes 3, 10, and 19, are crucial for causing Hirschsprung disease and together explain its complicated inheritance pattern. More...
These findings, reported in the April 15, 2002, online edition of Nature Genetics, show that it is important to consider all parts of a gene, not just those that carry instructions for a protein, when looking for contributors to disease.

"Just because coding sequences are not changed does not mean a gene is not involved,” explains Dr. Aravinda Chakravarti of Johns Hopkins University (Baltimore, MD, USA). "Many diseases likely have genetics similar to Hirschsprung disease, and we have shown that such complex genetic contributors can be discovered with a carefully designed study.”

Hirschsprung disease is a hereditary disorder, occurring in about one in 5,000 births, in which nerves that normally control the bowel are missing. Since the inheritance pattern is complex, researchers collected and analyzed samples from parents and children in 49 families, each with at least two affected siblings.

Each participant's genome was scanned and analyzed to find changes that might explain how Hirschsprung is passed from generation to generation. In particular, the scientists looked for "overshared” genetic regions in siblings with the disease, reasoning that these regions would be present more often than could be expected by chance alone. Of the many genetic differences found, computer analysis revealed that the changes within particular regions of chromosomes 3, 10, and 19 could explain both familial and non-familial cases of short-segment Hirschsprung disease. The short-segment form of Hirschsprung disease is both more common and more genetically complex than the long-segment form.

Gene mapping showed that there were no changes in protein-encoding areas of chromosome 10. "Mapping gives you an independent way of saying that this gene is involved in a disease, even if there are no changes in the coding sequence,” says Dr. Chakravarti. "This disease and many others are complex not just because they involve more than one gene, but because the molecular mechanisms behind the genes' involvement are unusual.” Changes in noncoding sequences can affect sites for regulation, carry instructions for alternative ways to read the gene, or otherwise alter gene function and expression.



Related Links:
Johns Hopkins

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.